Want to join the conversation?
$MYL expects the transaction to immediately add to its earnings, with accretion increasing significantly after the first full year (2017) as synergies are realized. The transaction will add $0.35-0.40 to $MYL's EPS in FY17 and will accelerate the achievement of the previously stated $6.00 adjusted diluted EPS target to FY17 versus FY18.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)